201T1 and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction: Comparison with equilibrium radionuclide angiography

Journal of Nuclear Medicine

Volumn 40, Issue 5, 1999, Pages 805-809

  Manrique, Alain ^a   Faraggi, Marc ^b   Véra, Pierre ^b   Vilain, Didier ^b   Lebtahi, Rachida ^b   Cribier, Alain ^b   Le Guludec, Dominique ^b  

^a CENTRE HENRI BECQUEREL   (France)

^b NONE

Author keywords

Ejection fraction; Gated SPECT; Methoxy isobutyl isonitrile; Thallium

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; THALLIUM;

ADULT; AGED; ARTICLE; CHANNEL GATING; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART PERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE QUALITY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; QUANTITATIVE DIAGNOSIS; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; GATED IMAGING; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; IMAGE PROCESSING; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING;

ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032587875     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
2. The Multicenter Post-Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
3. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
5. Cintron O, Johnson G. Francis G, Cobb F, Cohn JN, for the V-HeFT VA Cooperative Studies Group. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation. 1993;87(suppl VI):VI-17-VI-23.
6. Beller GA. Myocardial thallium-201 imaging for detection of myocardial viability. In: Zaret BL, Beller GA, eds. Myocardial Thallium-201 Imaging for Detection of Myocardial Viability. St. Louis, MO: Mosby; 1993:227-235.
7. Montalescot G, Faraggi M, Drobinski G, et al. Myocardial viability in patients with Q-wave myocardial infarction and no residual ischemia. Circulation. 1992;86:47-55.
8. Iskandrian AS, Jaekyeong H, Schelbert HR. Myocardial viability: methods of assessment and clinical relevance. Am Heart J. 1996;132:1226-1235.
9. Wackers FJ, Herman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxy-isobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion. J Nucl Med. 1989;30:301-311.
10. Heller GV. Tracer selection with different stress modalities based on tracer kinetics. J Nucl Cardial. 1996;3:S15-S21.
11. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138-2147.
12. Everaert H, Franken PR, Flamen P, Goris M, Momen A, Bossuyt A. Left ventricular ejection fraction from gated SPET myocardial perfusion studies: a method based on count rate density across the myocardial wall. Eur J Nucl Med. 1996;23:1628-1633.
13. DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med. 1993;34:1871-1876.
14. Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol. 1994;23:1107-1114.
15. 99mTc-MIBI. Nucl Med Commun. 1992;13:648-655.
16. Germano G, Erel J, Kiat H, Kavanagh PB, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT, J Nucl Med. 1997;38:749-754.
17. Maunoury C, Chen CC, Chua KB, Thompson CJ. Quantification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated SPECT. J Nucl Med. 1997;38:958-961.
18. Hurwitz GA, Saddy S, O'Donoghue JP, et al. The VEX-test for myocardial scintigraphy with thallium-201 and sestamibi: effect on abdominal background activity. J Nucl Med. 1995;36:914-920.
19. 99mTc-MIBI cardiac SPET interpretation. Nucl Med Commun. 1996;17:851-856.
20. Faraggi M, Steg PG, Francois D, et al. Residual area at risk after anterior myocardial infarction: are ST segment changes during coronary angioplasty a reliable indicator? A comparison with technetium 99m-labeled sestamibi single-photon emission computed tomography. J Nucl Cardiol. 1997;4:11-17.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
22. Williams KA, Taillon LA. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images: comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. J Am Coll Cordiol. 1996;27:173-181.
23. Mochizuki T, Murase K, Tanaka H, Kondoti T, Hamamoto K, Tauxe WN. Assessment of left ventricular volume using ECG-gated SPECT with technetium-99m-MIBI and technctium-99m-tetrofosmin. J Nucl Med. 1997;38:53-57.
24. Nichols K, DePuey G, Rozanski A. Automation of gated tomographic left ventricular ejection fraction. J Nucl Cardiol. 1996;3:475-482.
25. 99mTc-MIBI emission tomography and by magnetic resonance imaging. Eur J Nucl Med. 1996;23:909-916.
26. Gunning MG, Anagnostopoulos C, Davies G, Forbat SM, Ell PJ, Underwood SR. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess left ventricular contraction. J Nucl Med. 1997;38:438-442.
27. Wieshammer S, Hetzel M, Hetzel J, Henze E, Clausen M, Hombach V. Reproducibility of left ventricular volume measurements at rest and during bicycle exercise in patients with congestive heart failure: a combined radionuclide and haemodynamic study. Nucl Med Commun. 1996;17:591-595.
28. Ptisterer MA, Battler A, Swanson SM, Slutsky R, Froelicher V, Ashburn W. Reproducibility of ejection fraction determinations by equilibrium radionuclide angiography in response to supine bicycle exercise: concise communication. J Nucl Med. 1979;20:491-495.
29. Kuecherer HF, Kee LL, Modin G, Cheitlin MD, Schiller NB. Echocardiography in serial evaluation of left ventricular systolic and diastolic function: importance of image acquisition, quantification, and physiologic variability in clinical and investigational applications. J Am Soc Echocardiogr. 1991;4:203-214.
30. Himelman RB, Cassidy MM, Landzberg JS, Schiller NB. Reproducibility of quantitative two-dimensional echocardiography. Am Heart J. 1988;15:425-431.
31. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulaion. 1990;82:1629-1646.